Search results for "genetic variants"

showing 10 items of 32 documents

Development and validation of RP-HPLC method for the quantitative estimation of αs1-genetic variants in goat milk

2013

A high-performance liquid chromatographic (HPLC) method was developed and validated for separation and quantification of the most common genetic variants of as1-casein in goat’s milk, to evaluate the effect of as1-casein polymorphisms on casein content. Chromatography was carried out by binary gradient technique on a reversed-phase C8 Zorbax column and the detection was made at a wavelength of 214 nm. The procedure was developed using individual raw milk samples of Girgentana goats. For calibration experiments, pure genetic variants were extracted from individual milk samples of animals with known genotypes, considering that commercial standards for goat genetic variants were not available.…

ChromatographyGenotypeGoatsGenetic variantsCaseinsGenetic VariationGeneral MedicineRaw milkBiologyHigh-performance liquid chromatographyGirgentana goat breedAnalytical ChemistryGenetic variants as1-Casein HPLC Goat milkSettore AGR/17 - Zootecnica Generale E Miglioramento GeneticoMilkCaseinGenotypeAnimalsFood scienceAlleleChromatography High Pressure LiquidFood ScienceFood Chemistry
researchProduct

Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial.

2021

Abstract Background The single‐arm DAWN trial (NCT01779791) of ibrutinib monotherapy in patients with relapsed/refractory follicular lymphoma (FL) showed an overall response rate (ORR) of 20.9% and a median response duration of 19.4 months. This biomarker analysis of the DAWN dataset sought to determine genetic classifiers for prediction of response to ibrutinib treatment. Methods Whole exome sequencing was performed on baseline tumor samples. Potential germline variants were excluded; a custom set of 1216 cancer‐related genes was examined. Responder‐ versus nonresponder‐associated variants were identified using Fisher's exact test. Classifiers with increasing numbers of genes were created …

OncologyCancer ResearchFollicular lymphomaBiochemistrychemistry.chemical_compoundGenetic signaturePiperidinesRecurrenceMedicineExomeLymphoma FollicularExome sequencingRC254-282Research ArticlesNeoplasms. Tumors. Oncology. Including cancer and carcinogensHematologyDNA-Binding ProteinsExact testOncologyIbrutinibRefractory Follicular LymphomaClin oncolResearch ArticleGenetic Markersmedicine.medical_specialtyImmunologyAntineoplastic AgentslymphomaBiologyGermline mutationInternal medicinePartial responseExome SequencingHumansRadiology Nuclear Medicine and imagingIn patientbusiness.industryAdeninegenetic variantsClinical Cancer ResearchbiomarkersCell Biologymedicine.diseasemutationsFANCAMutational analysisCARD Signaling Adaptor ProteinschemistryGuanylate CyclaseFamily medicineRelapsed refractoryMutationbusinessCancer medicine
researchProduct

Relation Between Genetic Factors and Frailty in Older Adults.

2018

Frailty is a geriatric syndrome that identifies individuals at higher risk of disability, institutionalization, and death. We previously reported that frailty is related to oxidative stress and cognitive impairment-related biomarkers. The aim of this study was to determine whether frailty is associated with genetic variants.Longitudinal population-based cohort of 2488 community-dwelling people from Toledo, Spain, aged 65 years or older.We obtained blood samples from 78 individuals with frailty and 74 nonfrail individuals who were nonfrail (according to Fried criteria) from the Toledo Study of Healthy Ageing and extracted DNA using the Chemagic DNA blood kit.Sample genotyping was carried out…

GerontologyMaleAgingFrail ElderlyPopulationEnergy metabolismSingle-nucleotide polymorphismPolymorphism Single NucleotideCohort Studies03 medical and health sciences0302 clinical medicineMedicineHumansCognitive DysfunctionDisabled Persons030212 general & internal medicineeducationGenotypingExomeGeriatric AssessmentGeneral NursingGenetic Association StudiesAgedAged 80 and overeducation.field_of_studybusiness.industryHealth PolicyGenetic variantsCognitionGeneral MedicineSpainCohortFemaleGeriatrics and Gerontologybusiness030217 neurology & neurosurgeryJournal of the American Medical Directors Association
researchProduct

Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant.

2004

Background Highly publicised outbreaks of norovirus gastroenteritis in hospitals in the UK and Ireland and cruise ships in the USA sparked speculation about whether this reported activity was unusual. Methods We analysed data collected through a collaborative research and surveillance network of viral gastroenteritis in ten European countries (England and Wales were analysed as one region). We compiled data on total number of outbreaks by month, and compared genetic sequences from the isolated viruses. Data were compared with historic data from a systematic retrospective review of surveillance systems and with a central database of viral sequences. Findings Three regions (England and Wales,…

medicine.medical_specialtyvirusesmedicine.disease_causeDisease Outbreaks03 medical and health sciencesEpidemiologyEpidemic spreadmedicineHumans030304 developmental biologyCaliciviridae InfectionsRetrospective Studies0303 health sciencesInternational network030306 microbiologybusiness.industryNorovirusGenetic variantsOutbreakGenetic VariationGeneral MedicineNew variantVirology3. Good healthGastroenteritisEuropePopulation SurveillanceMutationNorovirusFood MicrobiologyViral diseaseSeasonsbusinessLancet (London, England)
researchProduct

Special Situations in APL

2017

The introduction of all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) as the mainstay therapy of acute promyelocytic leukemia (APL) has drastically changed the outcome of this hematologic malignancy into one of the first to receive a targeted treatment. Using frontline treatment strategies including these agents in combination with standard cytotoxic drugs has provided outstanding therapeutic results in most patients. In spite of the achievement of brilliant results in the majority of patients, some special situations still require the implementation of changes from the conventional therapeutic approach. In this chapter, we will review and discuss the management of APL in older and …

OncologyAcute promyelocytic leukemiamedicine.medical_specialtybusiness.industryGenetic variantsmedicine.diseaseLeukemiachemistry.chemical_compoundTherapeutic approachchemistryOlder patientsInternal medicinemedicineHematologic malignancyTreatment strategyArsenic trioxidebusiness
researchProduct

Association of genetic variants with pancreatic cancer

2007

AdultGeneticsCancer ResearchADP-Ribosylation FactorsGenes p16Association (object-oriented programming)Genes BRCA1Genetic variantsAdenocarcinomaMiddle AgedProtein Serine-Threonine KinasesBiologymedicine.diseasePancreatic NeoplasmsAMP-Activated Protein Kinase KinasesRisk FactorsPancreatic cancerMutationGeneticsmedicineHumansFemaleGenetic Predisposition to DiseaseMolecular BiologyCancer Genetics and Cytogenetics
researchProduct

Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD

2020

Background & aims: Neurotensin (NTS), a 13-aminoacid peptide localized in central nervous system and gastrointestinal tract, is involved in lipid metabolism and promotes various cancers onset mainly by binding to neurotensin receptor 1 (NTSR1). Increased plasma levels of pro-NTS, the stable NTS precursor, have been associated with type 2 diabetes (T2D), cardiovascular diseases and metabolic associated fatty liver disease (MAFLD). We aimed to evaluate 1) the impact of NTS rs1800832 and NTSR1 rs6090453 genetic variants on liver damage in 1166 MAFLD European individuals, 2) the relation between NTS variant and circulating pro-NTS and 3) the hepatic NTS expression by RNAseq transcriptomic a…

Male0301 basic medicineLiver damagemedicine.medical_specialtyGenetic variantsCarcinoma HepatocellularNeurotensin receptor 1CirrhosisTherapeutic targetSettore MED/12 - GASTROENTEROLOGIAType 2 diabetesGastroenterology03 medical and health sciencesLiver disease0302 clinical medicineFibrosisInternal medicinemedicineHumansReceptors NeurotensinBiomarker; Genetic variants; Lipid metabolism; Liver damage; Therapeutic targetMolecular BiologyNeurotensinAgedCell Proliferationbusiness.industryLiver NeoplasmsFatty liverBiomarker Genetic variants Lipid metabolism Liver damage Therapeutic targetCell BiologyBiomarkerMiddle Agedrespiratory systemmedicine.diseaseFibrosisFatty Liver030104 developmental biologyLipid metabolismDiabetes Mellitus Type 2Gene Expression Regulationnervous systemHepatocellular carcinomaMutationFemale030211 gastroenterology & hepatologybusinessHepatic fibrosiscirculatory and respiratory physiology
researchProduct

No association of alcohol dependence with a NMDA-receptor 2B gene variant

2003

Brain Chemistrymedicine.medical_specialtyLRP1BAlcohol dependenceGenetic variantsBiologyReceptors N-Methyl-D-AspartateMolecular biologyAlcoholismCellular and Molecular NeurosciencePsychiatry and Mental healthEndocrinologyInternal medicineNMDA receptor 2Bmedicinebiology.proteinHumansNMDA receptorGRIN2A5-HT5A receptorMolecular BiologyMolecular Psychiatry
researchProduct

PRELIMINARY STUDY ON QUANTIFICATION OF aS1-CASEIN VARIANTS IN GIRGENTANA GOAT BREED BY DIRECT CHROMATOGRAPHIC ANALYSIS OF MILK

2012

Goat αs1-casein is a highly polymorphic protein, coded by CSN1S1 gene. Nowadays, several alleles were identified and associated with different levels of αs1-casein in goat milk. Polymorphisms at αs1-casein locus have been shown to affect not only the quantity of this casein in goat milk, but also the structural and nutritional characteristics (hypoallergenic properties) and technological properties of the milk (1). The aim of this work was to separate and quantify the most common allelic variants of αs1-casein in milk of Girgentana goat breed, a Sicilian autochthonous breed, and to evaluate the effect of αs1-casein polymorphisms on casein content. The CSN1S1 A/01, B/E, F, and N alleles were…

HPLC genetic variants αs1-casein goat’s milk
researchProduct

Reconnoitering the Role of Long-Noncoding RNAs in Hypertrophic Cardiomyopathy: A Descriptive Review

2021

Hypertrophic cardiomyopathy (HCM) is the most common form of hereditary cardiomyopathy. It is characterized by an unexplained non-dilated hypertrophy of the left ventricle with a conserved or elevated ejection fraction. It is a genetically heterogeneous disease largely caused by variants of genes encoding for cardiac sarcomere proteins, including MYH7, MYBPC3, ACTC1, TPM1, MYL2, MYL3, TNNI3, and TNNT23. Preclinical evidence indicates that the enhanced calcium sensitivity of the myofilaments plays a key role in the pathophysiology of HCM. Notably, this is not always a direct consequence of sarcomeric variations but may also result from secondary mutation-driven alterations. Long non-coding R…

QH301-705.5CardiomyopathyTPM1ReviewBiologyCatalysisInorganic ChemistrymedicineHumansBiology (General)Physical and Theoretical ChemistryQD1-999Molecular BiologySpectroscopyGeneticslong non-coding RNAgenetic variantsOrganic ChemistryACTC1Hypertrophic cardiomyopathyGeneral MedicineCardiomyopathy Hypertrophichypertrophic cardiomyopathymedicine.diseaseLong non-coding RNAcardiovascular diseasesComputer Science ApplicationsChemistryMYL3Cardiovascular diseases Genetic variants Hypertrophic cardiomyopathy Long non-coding RNA Cardiomyopathy Hypertrophic Humans RNA Long NoncodingMYL2RNA Long NoncodingMYH7International Journal of Molecular Sciences
researchProduct